JP2022532370A5 - - Google Patents
Info
- Publication number
- JP2022532370A5 JP2022532370A5 JP2021568072A JP2021568072A JP2022532370A5 JP 2022532370 A5 JP2022532370 A5 JP 2022532370A5 JP 2021568072 A JP2021568072 A JP 2021568072A JP 2021568072 A JP2021568072 A JP 2021568072A JP 2022532370 A5 JP2022532370 A5 JP 2022532370A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1906870.9 | 2019-05-15 | ||
| GBGB1906870.9A GB201906870D0 (en) | 2019-05-15 | 2019-05-15 | Binding molecules |
| GB1906872.5 | 2019-05-15 | ||
| GBGB1906872.5A GB201906872D0 (en) | 2019-05-15 | 2019-05-15 | Binding molecules |
| PCT/GB2020/051199 WO2020229842A1 (en) | 2019-05-15 | 2020-05-15 | Binding molecules |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022532370A JP2022532370A (ja) | 2022-07-14 |
| JP2022532370A5 true JP2022532370A5 (https=) | 2023-05-23 |
| JPWO2020229842A5 JPWO2020229842A5 (https=) | 2023-05-23 |
Family
ID=70847430
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021568072A Pending JP2022532370A (ja) | 2019-05-15 | 2020-05-15 | 結合分子 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US20220220215A1 (https=) |
| EP (2) | EP3969474A1 (https=) |
| JP (1) | JP2022532370A (https=) |
| KR (1) | KR20220008839A (https=) |
| CN (1) | CN113840835B (https=) |
| AU (1) | AU2020275926A1 (https=) |
| CA (1) | CA3136598A1 (https=) |
| IL (1) | IL287555A (https=) |
| SG (1) | SG11202111671QA (https=) |
| WO (2) | WO2020229844A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7183163B2 (ja) | 2017-01-06 | 2022-12-05 | クレシェンド・バイオロジックス・リミテッド | プログラム細胞死（ｐｄ－１）に対するシングルドメイン抗体 |
| WO2019092452A1 (en) | 2017-11-13 | 2019-05-16 | Crescendo Biologics Limited | Molecules that bind to cd137 and psma |
| GB201802573D0 (en) | 2018-02-16 | 2018-04-04 | Crescendo Biologics Ltd | Therapeutic molecules that bind to LAG3 |
| EP4274852A4 (en) * | 2021-01-11 | 2025-02-26 | Eutilex Co., Ltd. | BISPECIFIC EPITOP-BINDING PROTEIN WITH ANTI-4-1BB ANTIBODY AND PD-1 PROTEIN OR FRAGMENTS THEREOF AND USE THEREOF |
| GB202205589D0 (en) | 2022-04-14 | 2022-06-01 | Crescendo Biologics Ltd | Mesothelin binders |
| JP2026506075A (ja) | 2023-02-17 | 2026-02-20 | アブリンクス エン．ヴェー． | 新生児型ｆｃ受容体に結合するポリペプチド |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0115256D0 (en) | 2001-06-21 | 2001-08-15 | Babraham Inst | Mouse light chain locus |
| US9321832B2 (en) * | 2002-06-28 | 2016-04-26 | Domantis Limited | Ligand |
| GB2398784B (en) | 2003-02-26 | 2005-07-27 | Babraham Inst | Removal and modification of the immunoglobulin constant region gene cluster of a non-human mammal |
| CA2671581A1 (en) * | 2006-12-05 | 2008-06-12 | Ablynx N.V. | Peptides capable of binding to serum proteins |
| US20130266567A1 (en) * | 2010-12-01 | 2013-10-10 | Haren Arulanantham | Anti-serum albumin binding single variable domains |
| CN106046168A (zh) * | 2011-06-23 | 2016-10-26 | 埃博灵克斯股份有限公司 | 结合血清白蛋白的蛋白 |
| US20130302250A1 (en) * | 2012-05-07 | 2013-11-14 | The University Court Of The University Of Aberdeen | Single domain binding molecule |
| WO2014111550A1 (en) * | 2013-01-17 | 2014-07-24 | Glaxosmithkline Intellectual Property Development Limited | Modified anti-serum albumin binding proteins |
| JP6641379B2 (ja) | 2014-10-22 | 2020-02-05 | クレシェンド・バイオロジックス・リミテッド | トランスジェニックマウス |
| JP7101621B2 (ja) * | 2016-05-20 | 2022-07-15 | ハープーン セラピューティクス，インク． | 単一ドメイン血清アルブミン結合タンパク質 |
| RU2022101604A (ru) * | 2016-12-07 | 2022-03-29 | Аблинкс Нв | Улучшенные отдельные вариабельные домены иммуноглобулина, связывающиеся с сывороточным альбумином |
| CN107674122A (zh) * | 2016-12-28 | 2018-02-09 | 天津天锐生物科技有限公司 | 一种识别人血清白蛋白的单域抗体 |
| JP7183163B2 (ja) * | 2017-01-06 | 2022-12-05 | クレシェンド・バイオロジックス・リミテッド | プログラム細胞死（ｐｄ－１）に対するシングルドメイン抗体 |
| GB201711068D0 (en) * | 2017-07-10 | 2017-08-23 | Crescendo Biologics Ltd | Therapeutic molecules binding PSMA |
| KR102625929B1 (ko) * | 2017-07-19 | 2024-01-16 | 브이아이비 브이지더블유 | 혈청 알부민 결합제 |
| EP3470426A1 (en) * | 2017-10-10 | 2019-04-17 | Numab Therapeutics AG | Multispecific antibody |
| WO2019092452A1 (en) * | 2017-11-13 | 2019-05-16 | Crescendo Biologics Limited | Molecules that bind to cd137 and psma |
-
2020
- 2020-05-15 CN CN202080035306.4A patent/CN113840835B/zh active Active
- 2020-05-15 US US17/610,330 patent/US20220220215A1/en not_active Abandoned
- 2020-05-15 SG SG11202111671QA patent/SG11202111671QA/en unknown
- 2020-05-15 EP EP20728166.8A patent/EP3969474A1/en not_active Withdrawn
- 2020-05-15 JP JP2021568072A patent/JP2022532370A/ja active Pending
- 2020-05-15 US US17/610,328 patent/US20220227850A1/en not_active Abandoned
- 2020-05-15 KR KR1020217038514A patent/KR20220008839A/ko not_active Ceased
- 2020-05-15 AU AU2020275926A patent/AU2020275926A1/en not_active Abandoned
- 2020-05-15 EP EP20728164.3A patent/EP3969473A1/en not_active Withdrawn
- 2020-05-15 CA CA3136598A patent/CA3136598A1/en active Pending
- 2020-05-15 WO PCT/GB2020/051201 patent/WO2020229844A1/en not_active Ceased
- 2020-05-15 WO PCT/GB2020/051199 patent/WO2020229842A1/en not_active Ceased
-
2021
- 2021-10-25 IL IL287555A patent/IL287555A/en unknown